NeuroSense Therapeutics

24 people · 0 jobs
‌

NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.

Industries

Headquarters

Herzliya, Israel

Employees

11-50

Links


Org chart

Alon Ben-Noon
Co-Founder & CEO
Collapse
Oron Yacoby-Zeevi
Chief Scientific Officer
Hagit Binder
VP, Operations
Diana Shtossel
Head of Regulatory Affairs
Keren Pushett
Head of HR

Board & advisors

Mark Leuchtenberger
Chairman, Board of Directors
Cary Claiborne
Member Board Of Directors; Audit Committee Chair
Jeremy Shefner
Scientific Advisor
Merit Cudkowicz
Scientific Advisor
Jinsy Andrews
Scientific Advisor
Orla Hardiman
Scientific Advisor
Jeffrey Rosenfeld
Scientific Advisory Board Member


Offices